NDC 0641-6182-01 - Orphenadrine citrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6182
- Requested NDC
- 0641-6182-01
- Package NDCs from labels
- 0641-6182-01, 0641-6182-10, 0641-6182-25
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ORPHENADRINE CITRATE INJECTION, USP | REMEDYREPACK INC. | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
| ORPHENADRINE CITRATE INJECTION, USP | Hikma Pharmaceuticals USA Inc. | 2024-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6182-01 | Orphenadrine citrate | 2 mL in 1 VIAL | INJECTION | 2 | 5 | |
| 0641-6182-10 | Orphenadrine citrate | 10 in 1 BOX | INJECTION | 10 | 5 | |
| 0641-6182-25 | Orphenadrine citrate | 25 in 1 BOX | INJECTION | 25 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6182-01 | ML - Milliliter | 0641-6182 | 5a19407b-dbd6-4797-b8d8-790c93f12ff2 | 1 | 2017-12-14 |
| 0641-6182-10 | ML - Milliliter | 0641-6182 | 284eaedf-e0c9-4cbb-8ffd-b2aef877b3f3 | 1 | 2017-12-14 |
| 0641-6182-25 | ML - Milliliter | 0641-6182 | 2bd52cb8-76de-4bc5-ae3b-28e12563bf9d | 1 | 2024-09-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.